Skip to main content
Fuan Pharmaceutical （Group）co.,Ltd logo

Fuan Pharmaceutical （Group）co.,Ltd — Investor Relations & Filings

Ticker · 300194 ISIN · CNE1000011G4 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,014 across all filing types
Latest filing 2016-05-18 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300194

About Fuan Pharmaceutical （Group）co.,Ltd

https://www.fapharm.com

Fuan Pharmaceutical (Group) Co., Ltd. is an integrated pharmaceutical enterprise specializing in the research, development, production, and distribution of a wide range of chemical drugs. The company operates across the entire value chain, encompassing pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and finished dosage forms. Its product portfolio primarily focuses on anti-infectives, particularly cephalosporins and penicillins, as well as treatments for cardiovascular diseases, oncology, and respiratory conditions. Fuan Pharmaceutical maintains large-scale manufacturing facilities and emphasizes technological innovation to support its diverse pipeline of generic and specialized medications. The group serves both domestic and international markets, providing essential healthcare solutions through its network of subsidiaries and specialized production bases.

Recent filings

Filing Released Lang Actions
关于发行股份及支付现金购买资产之标的资产过户完成的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the completion of asset acquisition through issuance of shares and cash payment by the company 福安药业 (Fuan Pharmaceutical). It details the completion of equity transfer, registration of the acquired subsidiary, and outlines subsequent steps such as payment of remaining cash consideration and registration of new shares. The document includes opinions from independent financial advisors and legal counsel confirming the legality and completion of the transaction steps. The content focuses on a capital transaction involving issuance of shares and acquisition of assets, rather than a full financial report or earnings release. The document length is short (1314 characters) and it is an announcement of a completed capital transaction, not a detailed financial report or audit. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2016-05-18 Chinese
上海东方华银律师事务所关于公司发行股份及支付现金购买资产并募集配套资金暨关联交易之标的资产过户的法律意见书
Capital/Financing Update Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the issuance of shares and payment of cash to purchase assets and raise supporting funds, including related party transactions and the transfer of the target assets. It details the approval procedures by the company, target company, transaction counterparties, regulatory authorities (China Securities Regulatory Commission), and business departments. It confirms the completion of the asset transfer registration and legal compliance of the transaction. The document is a standalone legal opinion related to a capital transaction and asset acquisition, not a financial report, earnings release, or regulatory announcement. It is not a full audit report but a legal opinion on a specific transaction. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes.
2016-05-18 Chinese
2015年度权益分派实施公告
Notice of Dividend Amount Classification · 100% confidence The document is titled as an announcement regarding the implementation of the 2015 annual equity distribution (dividend) plan approved at the 2015 Annual General Meeting. It details the dividend amount per share, the record date, the ex-dividend date, the dividend payment method, and related shareholder information. The document is relatively short (1713 characters) and serves as a formal announcement of the dividend distribution rather than a full financial report or detailed analysis. It does not contain comprehensive financial statements or management discussion. Therefore, it fits the category of a Notice of Dividend Amount (DIV).
2016-05-18 Chinese
关于控股股东部分股份质押的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement regarding the pledge of shares by a controlling shareholder. It details the number of shares pledged, the dates, the pledgee, and the purpose of the pledge. There is no financial report, earnings data, or management discussion. The content fits the description of a Capital/Financing Update, as it relates to changes in the company's capital structure through share pledging. The document length is short and focused solely on this financing activity, not an annual or interim report or other types of filings.
2016-05-18 Chinese
关于公司监事辞职的公告
Board/Management Information Classification · 100% confidence The document is a short announcement regarding the resignation of a company supervisor (监事) from 福安药业. It details the resignation letter, the reason for resignation, and the impact on the supervisory board. There is no financial data, no mention of financial results, no regulatory certifications, or report attachments. The content is about a change in company management personnel, specifically a supervisory board member's resignation. This fits the category of Board/Management Information (MANG). The document length is short and focused solely on this personnel change, confirming it is not a full report or announcement of a report publication.
2016-05-18 Chinese
2015年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a resolution announcement from the 2015 Annual General Meeting (AGM) of 福安药业 (Fuan Pharmaceutical Group Co., Ltd.). It details the voting results on various agenda items including approval of the 2015 annual reports, financial statements, audit reports, profit distribution plans, and appointment of auditors. The document also includes legal opinions on the meeting's legality and compliance. The content is focused on the outcomes of the shareholder meeting and the resolutions passed, rather than the full annual report or financial statements themselves. The document length is about 9,000 characters, which is substantial but the content is clearly a formal announcement of the AGM resolutions and voting results. Therefore, this fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2016-05-16 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.